Metformin inhibits the TOR pathway in breast cancer cells (Dowling et al., 2007), and in C. elegans, it inhibits TORC1 through suppression of mitochondrial respiration, linking energy metabolism with the TOR signaling pathway (Dowling et al., 2007, Wu et al., 2016). This evidence concerns the gene CRTC1 and breast carcinoma.